CMS announces new repayment terms for Accelerated and Advance Payment programs

Oct 09, 2020 - 01:45 PM
CMS logo

The Centers for Medicare & Medicaid Services yesterday announced new repayment terms for payments received under its Accelerated and Advance Payment programs, including a longer time period before repayment, lower recoupment rates during repayment, lower interest on remaining unpaid balance, and additional repayment flexibilities.

The announcement implements provisions of the Continuing Appropriations Act, 2021 and Other Extensions Act, which was enacted on Oct. 1, 2020.

The repayment terms are amended for all providers and suppliers who requested and received AAPs during the COVID-19 public health emergency. In addition to describing the new terms, CMS announced that the agency no longer will accept applications for AAPs as they relate to COVID-19. CMS also clarified that Provider Relief Funds can be used toward repayment of these Medicare loans.

Related News Articles

Headline
HHS announces new 340B Rebate Model Pilot Program
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
Lawmakers introduce bill codifying 340B providers’ use of contract pharmacies to dispense discounted drugs
Rep. Doris Matsui, D-Calif., and Sen. Peter Welch, D-Vt., today introduced the 340B Patients Act, AHA-supported legislation that would codify 340B providers'…
Headline
AHA files brief defending Colorado’s 340B contract pharmacy law
The AHA July 16 filed an amicus brief in the U.S. District Court for the District of Colorado in defense of the state’s 340B contract pharmacy law prohibiting…
Headline
FDA announces recall of cefazolin by Sandoz for mislabeling
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium…
Headline
Missouri district court rules in favor of state’s 340B law
The U.S. District Court for the Eastern District of Missouri July 11 granted a motion by the state to dismiss claims by AbbVie that the state’s 340B contract…
Headline
COVID-19 vaccination approved for older adults and high-risk, younger children
 The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that…